ATI PN Pharmacology 2020 | Nurselytic

Correct Answer: D

Rationale: The correct answer is D: Reduced bronchial inflammation. Montelukast is a leukotriene receptor antagonist commonly used to manage asthma symptoms by reducing inflammation in the airways. The medication works by blocking the action of leukotrienes, which are chemicals in the body that cause inflammation, bronchoconstriction, and mucus production in the lungs.
Therefore, the expected therapeutic effect of montelukast is to reduce bronchial inflammation, leading to improved breathing and asthma control.


Choice A (Improved peripheral vasodilation) is incorrect because montelukast does not have a direct effect on peripheral vasodilation.
Choice B (Increased WBC Count) is incorrect as montelukast does not affect white blood cell count.
Choice C (Neutralized gastric acid) is incorrect because montelukast is not used for this purpose.

Correct Answer:

Rationale:

Correct Answer:

Rationale:

Correct Answer:

Rationale:

Correct Answer:

Rationale: